NewAmsterdam Pharma N.V. (NAMS)
21.77
-0.64 (-2.86%)
At close: Mar 28, 2025, 3:59 PM
21.45
-1.48%
After-hours: Mar 28, 2025, 05:37 PM EDT
NewAmsterdam Pharma Analyst Ratings
Total Analysts
6
Consensus Rating
Buy
Price Target
42
Upside
92.93
Ratings History
| Analyst | Firm | Rating | Action | Price Target | Upside | Date |
| Scotiabank | Buy | Maintains | 47 52 | 138.86% | Feb 27, 2025 | |
| Needham | Buy | Maintains | 46 42 | 92.93% | Feb 27, 2025 | |
| RBC Capital | Buy | Initiates | 40 40 | 83.74% | Jan 28, 2025 |
Trade Smarter, Not Harder
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.